Human Tetanus Immunoglobulin is used in the treatment and prevention of Tetanus.
🛒 How to order this item?
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
No interaction was found/established. Please consult your doctor before using Tetagam-P 250 IU/ml Injection.
If you are pregnant, consult, and seek advice from your doctor before receiving Tetagam-P 250 IU/ml Injection.
Please tell your doctor, if you are a breastfeeding mother before receiving Tetagam-P 250 IU/ml Injection.
There are no known effects of Tetagam-P 250 IU/ml Injection on your ability to drive or operate machinery.
If you have or have a history or evidence of any liver-related diseases, please consult the doctor before taking Tetagam-P 250 IU/ml Injection.
If you have or have a history or evidence of any kidney-related diseases, please inform the doctor before taking Tetagam-P 250 IU/ml Injection.
Tetagam-P 250 IU/ml is indicated for:
It works by giving your body the antibodies it needs to protect it against tetanus infection.
Injection-site reactions such as pain, soreness, and tenderness may occur. Other rare side effects include increased temperature, angioneurotic edema, nephrotic syndrome, and anaphylactic shock.
Tetagam-P 250 IU/ml prevents tetanus toxoid from damaging tissue by binding to it, interfering with its interaction with human tissue. This prevents the toxoid from invading the nervous system and causing symptoms such as painful muscle spasms and autonomic dysfunction. The Clostridium tetani bacterium is killed by antibiotic treatment or the host's immune system, and the immune globulin-bound toxoid is likely broken down by immune cells.
Adult Dose:
Child Dose: Same as adult dose.
Tetagam-P 250 IU/ml should only be administered intramuscularly. It should not be given intravenously. Care should be taken to use separate syringes for each patient to prevent transmission of infectious diseases. The injection site should be compressed after administration. It should not be given subcutaneously except in cases of severe coagulation disorders where intramuscular injection is contraindicated.
Tetagam-P 250 IU/ml may reduce the efficacy of live vaccines.
The safety of human tetanus immunoglobulin in pregnancy has not been established in controlled clinical trials. However, long-lasting clinical experience with immunoglobulins suggests that no harmful effects on the course of pregnancy, fetus, or neonate are expected.
Tetagam-P 250 IU/ml should be stored at +2°C to +8°C, protected from light, and kept out of reach of children. It should not be frozen, and any frozen product should be discarded.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.